8-K//Current report
Tribute Pharmaceuticals Canada Inc. 8-K
Accession 0001354488-15-005412
CIK 0001159019operating
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 7, 9:02 PM ET
Size
2.1 MB
Accession
0001354488-15-005412
Documents
- 8-Ktbuff_8k.htmPrimary
CURRENT REPORT
- EX-2.1tbuff_ex2.htm
AMENDMENT NO. 1 TO THE AGREEMENT AND PLAN OF MERGER AND ARRANGEMENT, DATED AUGUST 19, 2015, BY AND AMONG POZEN, TRIBUTE, FORMER PARENT, HOLDINGS, FORMER US MERGER SUB, US MERGER SUB, AND CAN MERGER SUB.
- EX-2.2tbuff_ex21.htm
AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF
- EX-10.1tbuff_ex101.htm
SECOND AMENDED AND RESTATED FACILITY AGREEMENT
- EX-10.2tbuff_ex102.htm
SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT
- EX-10.3tbuff_ex103.htm
AMENDED AND RESTATED SHARE SUBSCRIPTION AGREEMENT
- EX-99.1tbuff_ex991.htm
PRESS RELEASE
- GRAPHICpozen.jpg
- GRAPHICtribute.jpg
Issuer
Tribute Pharmaceuticals Canada Inc.
CIK 0001159019
Entity typeoperating
IncorporatedOntario, Canada
Related Parties
1- filerCIK 0001159019
Filing Metadata
- Form type
- 8-K
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 7, 9:02 PM ET
- Size
- 2.1 MB